Tweenvest Stocks

Nuvectis Pharma, Inc. (NasdaqCM: NVCT)

Health Care · Biotechnology · US

$19.69

-6.77% today · +241.2% 1Y

Nuvectis Pharma, Inc. (NasdaqCM: NVCT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $688.12M and employs 16 people.

Over the last twelve months the share price has gained 241.2%, trading between 5.55 and 29.28.

Tweenvest scores Nuvectis Pharma, Inc. across four factors: quality 35/100, value 89/100. Its strongest factor is value.

NVCT price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$688.12M
Revenue (TTM)
—
P/E
—
EPS
-1.30
Dividend yield
—
Beta (5Y)
-0.24
52-week high
$29.28
52-week low
$5.55
Avg volume (3M)
—
Shares outstanding
32.58M
Employees
16
Next earnings
—

About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.

ISIN
US67080T1088
Founded
2020
Listed since
Feb 4, 2022
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Avalo Therapeutics, Inc.NasdaqCM: AVTX$710.06M$13.24-3.00%
MiMedx Group, Inc.NasdaqCM: MDXG$704.02M$4.83+3.43%
Pharming Group N.V.ENXTAM: PHARM$691.81M€0.88-0.16%
Kexing Biopharm Co., Ltd.SHSE: 688136$689.04MCN¥23.24-4.24%
Olema Pharmaceuticals, Inc.NasdaqGS: OLMA$684.23M$7.36-5.88%
Design Therapeutics, Inc.NasdaqGS: DSGN$682.77M$10.91-6.35%
Aura Biosciences, Inc.NasdaqGM: AURA$678.23M$6.540.00%
Qurient Co., Ltd.KOSDAQ: A115180$676.80M₩22,350.00-9.70%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.